A B S T R A C T Raji cells were used for the isolationi of complement-fixing antigen-antibody complexes from serum. Immune complexes bound to these cells were radiolabeled at the cell surface with lactoperoxidase. The complexes were then eluted from the cells with isotonic citrate buffer pH 3.2 or recovered by immunoprecipitation of cell lysates. The antigen and antibody moieties of the complexes were isolated by dissociating sucrose density gradient centrifugation or by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. A variety of preformed immune complexes were successfully isolated from serum with this approach. In addition, these techniques were used to isolate and identify the antigens in immuine complexes in the serum of rabbits with chronic serum sickness and rats with Moloney virus-induced sarcomas.
A B S T R A C T Raji cells were used for the isolationi of complement-fixing antigen-antibody complexes from serum. Immune complexes bound to these cells were radiolabeled at the cell surface with lactoperoxidase. The complexes were then eluted from the cells with isotonic citrate buffer pH 3.2 or recovered by immunoprecipitation of cell lysates. The antigen and antibody moieties of the complexes were isolated by dissociating sucrose density gradient centrifugation or by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. A variety of preformed immune complexes were successfully isolated from serum with this approach. In addition, these techniques were used to isolate and identify the antigens in immuine complexes in the serum of rabbits with chronic serum sickness and rats with Moloney virus-induced sarcomas.
Methods were also developed for the production of' antisera against the antigenic moiety of immune complexes isolated from serum. Repeated challenge of' rabbits with whole Raji cells with bound complexes or eluates from such cells resulted in antibody production against the antigens of the immune complexes, although reactivity against cellular and serum components was also elicited. Monospecific antisera against the antigens in immune complexes were produced by immunizing rabbits with the alum-precipitated antigen isolated on sodium dodecyl sulfatepolyacrylamide gel electrophoresis. These techni(ues INTRODUCTION Immune complex (IC)' formation results from the sequence in which antibody combines with antigen during normal immune responses. Although this process usually benefits the host, ICs may cause phlogogenic reactions or interfere with immunologic meehanisms (1) (2) (3) (4) . 'With the refinement of' the necessary techni(ues andl the use of appropriate experimental models, the pathogenic role of' circulating ICs in diseases of animals and man is becoming increasingly clear (5) (6) (7) (8) (9) (10) (11) . Exogenous as well as endogeinouis antigeins can trigger pathogeinie immune responises (6) , although in many IC diseases the responsible antigens are not identified. One meanis of' identifving and characterizing these antigens would be the isolation of ICs. Onee the ICs are isolated, the antigens might be identified directly or after the dissociation of antigens from antibody and the subse(qtuent isolation of the antigenic moiety of'the complex. The best souirces from which to isolate ICs then are: (a) tissues with immune deposits, (b) serum with circulating ICs, aind (c) mononuclear cells with ICs absorbed in vivo via suirfhace Fe and C receptors. ICs deposited in tisstues, notably in the kidneys, have been eluted with a variety of dissociating agents (7, (12) (13) (14) , and their contents of both antigens and antibodies have been recovered, quantitated, and characterized in many diseases. However, because tissues are not always available and because ICs in serum do not always deposit in tissues, the alternative sources-serum and leukocytes-may provide a more convenient material for isolation of ICs. This paper describes a method of isolating ICs from the serum with Raji cells that bind C-fixing ICs (15) (16) (17) . After isolation, the ICs can be concentrated and characterized via appropriate immunochemical and electrophoretic techniques. Such preparations can then be used to raise antisera against the antigenic moiety of the IC.
METHODS
Cell lines. Raji cells (18) were cultured in Eagle's minimal essential medium (MEM) as has been described (15) . Cell viability was determined by trypan blue exclusion. Previously, uptake experiments on synchronized cell cultures have indicated that receptors for IgG Fc and C on these cells are expressed equally well throughout the cell cycle (16) . Wil2W'T cultured cells are derived from the spleen of a patient with hereditary spherocytic anemia and are devoid of receptors for IgG Fc or human C.
Antigens and antisera. Bovine serum albumin (BSA) and human serum albumin (HSA) were purchased from Miles Laboratories Inc. (Elkhart, Ind.). The envelope glycoprotein gp7O and the major internal protein p30 from Rauscher murine leukemia virus were purified as described (19) . Purified tetanus toxoid (lot 8086, 2,083 Lf/ml, 1,197 Lf/mg protein N) was prepared at the Department of Public Health, Division of Disease Control and Laboratory Services, State of Michigan, and supplied by Dr. G. R. Anderson. Human IgG, rabbit IgG, and human C3b were prepared as described (15, 16) . Solutions of these proteins were prepared in phosphate-buffered saline (PBS).
Antiserum to purified Moloney virus p30 was prepared in Brown-Norway (BN) rats and supplied to us together with the antigen p30 by Dr. J. Jones (Scripps Clinic and Research Foundation, La Jolla, Calif.). Goat antisera to Moloney virus gp7O and to Rauscher virus p30 were obtained from the National Cancer Institute (National Institutes of Health, Bethesda, Md.). Tetanus immune human globulin (lot 14) was a gift from Dr. G. R. Anderson. Antiserum to BSA, to human IgG, and to goat gamma globulin were produced in rabbits, antiserum to rabbit IgG in sheep, and antiserum to HSA in mice. Monospecific antisera to purified Clq, C4, C3, C5, C6, C7, C8, C9, factor B, and properdin were prepared in rabbits or goats and provided by Dr. C. Arroyave (Scripps Clinic and Research Foundation). The IgG fraction of these antisera was used in some experiments and was isolated by DEAE-52-cellulose column chromatography (16) . The IgG fraction of the rabbit anti-BSA serum and anti-C3 serum and of the sheep anti-rabbit IgG serum was conjugated with fluorescein isothiocyanate (FITC) as described (20) .
Preparation of soluble ICs. Quantitative precipitin curves were constructed for the above antigen-antibody systems. A constant amount of antigen was mixed with trace amounts of 1251-radiolabeled antigen and then reacted (37°C, 30 min and 4°C, overnight) with increasing amounts of the corresponding antiserum. The precipitates obtained after centrifugation were washed twice with cold physiologic saline and counted in a gamma counter. Subsequently, the precipitates were dissolved in 1 ml of 0.1 N NaOH, and the protein was quantitated by OD reading at 280 nm. 300 ,ul of8 M urea-1% SDS solution, supplemented with 1311-labeled marker proteins, and subjected to SDS-polyacrylamide electrophoresis (PAGE) analysis. In techniques II and III, gels were sectioned into 1-mm slices with an automatic slicer (Loyce Loebl gel slicer, The Mickle Laboratory Engeen, Inc., Eng.) and counted in a two-channel gamma counter. In some experiments radioactive gel slices were incubated overnight in 0.2 ml H20, and counts released were determined.
Pathological sera. Sera from rabbits with experimentally induced chronic serum sickness to BSA were obtained before and 10 min after the daily injection of BSA. These sera were kindly supplied by Dr. C. B. Wilson (Scripps Clinic and Research Foundation). The amount of BSA injected into these rabbits was predetermined on the basis of their anti-BSA antibody titers (25) .
Sera from BN rats receiving 2 x 107 syngeneic Moloneyinduced sarcoma tumor cells were obtained before and at different times after tumor transplantation. The rat sera were provided by Dr. C. Jennette (Scripps Clinic and Research Foundation) and assessed for levels of ICs (expressed as micrograms aggregated rat IgG e(quivalent per milliliter serum) by a modification of the Raji cell assay (26 . Cells were washed, surface labeled with 1251 by the lactoperoxidase method, washed again, and eluted with 300 ul of citrate buffer. The eluates were dialyzed against citrate buffer, supplemented with 131I-marker antigen and IgG, applied on a 10-25% sucrose gradient in citrate buffer, and ultracentrifuged (15 h, 135,000 g). 10-drop fractions were collected from the bottom and counted in a twochannel gamma counter. The position of the 1311 markers is indicated by the arrows.
antigens and antibodies are observed. By incubating cells with serum containing various amounts of BSAanti-BSA complexes, it was found that at least 100 ,ug BSA complexed with antibody per milliliter serum (i.e. 20 ,ug added to cells) were necessary to produce distinct peaks of radioactivity. From 46-63% of the released antigen was recovered after centrifugation of 1251-BSA-anti-BSA-C complexes. Upon recovery of the antigen and antibody from the gradient and their subsequent neutralization, recombination, and ultracentrifugation in neutral sucrose density gradient, radioactivity shifted toward the bottom of the gradient associated with disappearance of the radioactive peaks that represented the uncombined antigen and antibody (Fig. 5) . This finding indicates the capacity of the recovered reactants to recombine and form ICs. (Fig. 7) . Addition of varying amounts of BSA-anti-BSA-C or HSA-anti-HSA-C complexes to 3 x 107 Raji cells indicated that under the conditions employed a minimum of 25 To determine the efficacy ofthe SDS-PAGE in recovering antigen, 1251-labeled BSA was reacted with antibody and C and bound to the surfaces ofRaji cells. These cells were then processed as in the lactoperoxidase labeling method but without the addition of further 125I. After elution and SDS-PAGE, from 67-73% of the released antigen was recovered, whereas after solubilization-immunoprecipitation and SDS-PAGE, from 79-85% of the immunoprecipitated antigen was recovered in the gels. Greater than 95% of the polyacrylamide gel-associated antigen was eluted in H20.
Isolation and characterization of antigens in IC absorbed to Raji cells from pathological sera. The techniques used to isolate preformed in vitro ICs in sera were next applied to isolating ICs from pathological animal sera. We first examined sera from three rabbits with BSA-induced chronic serum sickness. Fig. 8 pictures the profile of citrate buffer eluates obtained from Raji cells incubated in sera of a representative one of these rabbits. Peaks of 125I radioactivity and peak IV comigrated with the marker p30. The 1251 peaks became more pronounced at 40 days postinoculation when the animal had a large tumor and higher levels of circulating ICs. To demonstrate that the 125I peaks comigrating with the 131I-radiolabeled gp7o and p30 markers were related to Moloney virus gp70 and p30 the following procedure was performed. Gel slices corresponding to gp7O and p30 markers were eluted with H20; eluates were supplemented with rabbit IgG (1 mg/ml) and dialyzed against PBS for 6 h. Subsequently, the eluates were divided into two equal portions; one was treated with goat anti-Moloney gp7O or goat anti-Rauscher p30 and rabbit anti-goat antibody at equivalence and the other with normal goat serum and rabbit anti-goat IgG antibody. 38% of the 125I counts eluted from the slices corresponding to the gp7O marker and 53% of the 125I counts eluted from the slices corresponding to p30 marker coprecipitated with the corresponding goat antisera as opposed to 6.7 and 1.3% with the normal goat serum. This finding indicated that the 125I peaks III and IV represented Moloney virus envelope gp7O and core p30 proteins. To demonstrate that Raji-cell bound gp7O and p30 were complexed with IgG, the citrate buffer eluate obtained from surface-iodinated Raji cells, which had been incubated with an IC-containing rat serum, was neutralized by ovemight dialysis against PBS and treated with 50% ammonium sulfate.
The supernate obtained after removing the precipitate by centrifugation was dialyzed against 8 M urea-1% SDS, supplemented with 131I-marker proteins and subjected to SDS-PAGE analysis. In contrast to the nonammonium sulfate-treated eluate obtained from surface-iodinated Raji cells incubated with the same serum, the ammonium sulfate-treated eluate did not show 125I-labeled peaks of gp70 and p30 upon SDS-PAGE analysis. Only 15% of noncomplexed isolated 125I-gp70 and 125I-p30 in PBS were precipitated after treatment with 50% ammonium sulfate. In addition, eluates obtained from surface-iodinated Raji cells incubated in 5 ,ug purified gp70 or 5 ,ug purified p30 demonstrated no peaks of radioactivity, indicating that these isolated proteins did not bind by themselves to Raji cells. The nature of peak II was not determined.
Production of antisera against antigens in Raji cell-bound ICs. The reactivity of tetanus toxoid against serum obtained from a rabbit immunized i.v. with whole Raji cells with bound tetanus toxoid-antitetanus toxoid-C complexes (technique I) is illustrated in Fig. 10 . In the same figure the reactivity of tetanus toxoid against serum obtained from a rabbit immunized with complete Freund's adjuvant mixed with salinedialyzed citrate buffer eluate derived from Raji cells with bound complexes (technique II) is also shown. The antiserum against whole IC-bearing Raji cells was more potent (1:128 antibody titer) than the antiserum against the eluate (1:8 antibody titer) as determined by Ouchterlony analysis. Additionally, the antiserum against whole IC-bearing Raji cells contained anti-Raji cell antibodies demonstrated by a complement-dependent cytotoxicity test. Antiserum raised against the eluate lacked reactivity with Raji cells. Neither antisera reacted with isolated human IgG indicating that the rabbits were tolerant to human IgG. However, both antisera produced two precipitin lines upon double immunodiffusion with NHS. The first of the two lines was caused by antibodies to HSA as shown by identity with an anti-HSA serum upon double immunodiffusion against NHS. The second, thinner line showed non-identity with IgM, IgA, and most C components and could not be identified further. However, both lines could completely be removed by one absorption of the antisera with glutaraldehyde-insolubilized NHS. Control animals injected i.v. with washed Raji cells incubated with tetanus toxoid alone or tetanus toxoid-antitetanus toxoid in heated serum did not produce antibodies to the antigen.
Antiserum to BSA was obtained similarly by injecting rabbits i.v. with whole BSA-anti-BSA-C bearing Raji cells or with citrate buffer eluates obtained from Raji cells bearing BSA-anti-BSA-C complexes. Control animals injected with washed Raji cells incubated in FIGURE 10 Production of antibodies to antigens in isolated immune complexes. Sera were obtained from rabbits tolerant to human IgG and that had been injected with either whole Raji cells carrying tetanus toxoid-human antitetanus toxoid-C complexes (A), with citrate buffer eluates from Raji cells carrying the complexes (B), or with whole Raji cells incubated with tetanus toxoid alone (C). Peripheral wells contain serial twofold dilutions of the respective rabbit antisera, and central wells contain tetanus toxoid (1 mg/ml).
Spinner's medium, BSA alone, or BSA-anti-BSA in heated serum failed to produce anti-BSA antibodies. Moreover, animals injected with washed Wil2WT cells (devoid of Fe and C receptors) incubated with BSAanti-BSA-C complexes did not produce anti-BSA antibodies.
To avoid antigenic competition and to produce antisera that would react only with the antigen in the IC, another approach was utilized (technique III). In this method, eluates obtained from surface-iodinated Raji cells bearing HSA-anti-HSA-C complexes were first electrophoresed on SDS-polyacrylamide gels. The 125I radioactivity corresponding to the trace 1311_ HSA marker was eluted, and the eluates from three such gels were combined and precipitated with alum. The precipitates were solubilized in saline and injected into rabbits. An antiserum was produced that reacted only with HSA but not with the cells or any component in normal mouse serum used as a source of antibody and C.
DISCUSSION
We have developed procedures by which antigens in ICs can be isolated from serum. First, C-fixing ICs were separated from serum and concentrated on C receptor-bearing Raji cells. Then, these cell-bound ICs were radiolabeled and eluted from intact cells or immunoprecipitated from cell lysates. Finally, the constituent antigens and antibodies were separated under dissociating conditions. Past efforts to detect and isolate circulating ICs involved such physicochemical methods as gradient centrifuigation, column chromatography, and precipitation in the presence of polyethylene glycol, ammonium sulfate, or low temperature. Recently, methods involving more specific interactions have been developed for the detection of ICs. These methods utilize serum proteins such as Clq (28), rheumatoid factor (9), and conglutinin (29, 30) , as well as cells with Fc and C receptors (3, 16 In our SDS-PAGE system we used 7.5% gels, with an expected exclusion limit of 180,000 daltons. This presented no difficulty because the antigens used to prepare in vitro models of ICs were <180,000 daltons in molecular weight. However, these gels could fail to demonstrate large unknown antigens in IC-containing sera. On the other hand, we might expect many pathological ICs to contain small antigens because isolated viral and cellular antigens have been found in general to have a mol wt of 100,000 daltons or less. It could be considered that for initial screening purposes use of dissociating sucrose density gradients or 4-10% gradient SDS-polyacrylamide gels may be preferable.
The methods developed in this study were used to isolate ICs from sera of rabbits with serum sickness and from rats with syngeneic Moloney sarcoma tumors, both models of' human diseases for which these procedures should be useful. In the serum sickness model it was possible to isolate BSA-anti-BSA complexes and to separate the antigen from the antibody. The demonstration of ICs in eluates derived from Raji cells incubated with rabbit sera obtained before and after the daily injection of the antigen indicates the efficacy of these cells in absorbing ICs at both antibody and antigen excess.
Jennette and Feldman (26) and Jones et al. (34) , using Moloney sarcoma virus-induced tumors in rats, have developed an excellent model of IC-associated malignancy. In our study of the sera of such rats, we have indicated that gp7O and p30 are present in the circulating ICs. Thus, SDS-PAGE analysis of Raji celleluted material showed 70,000 and 30,000 mol wt peaks that are partially immunoprecipitated by antisera to gp7O and p30, respectively. These peaks are absent if the eluates are precipitated with ammonium sulfate before electrophoresis. In addition, we demonstrated that neither gp7O nor p30 alone bound to Raji cells. Of course, our present demonstration of gp7O-anti-gp7O and p30-anti-p30 ICs in these sera does not exclude the possible presence in low levels of other IC systems composed of alloantigens or tumor-specific antigens and their corresponding antibodies.
Although Raji cells are obviously useful in recovering ICs from sera, it would be difficult by this technique to isolate large (uantities of ICs for detailed studies. Therefore, we considered it important to develop techniques for producing antisera against antigens in isolated ICs. With whole IC-bearing Raji cells or eluates from these cells, antisera were produced against both a relatively poor immunogenic material (BSA) and a strongly immunogenic one (tetanus toxoid). The production of antiserum against BSA with small quantities (-6-7 ,tg) of cell-bound or soluble complexed antigen is in accord with other studies which indicate that complexed antigens can be more immunogenic than free antigens (35) . In the case of free BSA, injection of -100 ,ug of antigen has been found to be necessary for induction of antibodies (36) . Although only two rabbits were looked at with each technique, the cell-bound complexed antigens appear to be superior to eluted complexed antigens in the production of antisera. This may be the result of different handling or of the presence of higher amounts of antigen on cells than in eluates. However, injection of whole cells or eluates is complicated by the formation of antibodies against other serum proteins and Raji cells. Monospecific antiserum to antigens in isolated ICs from serum was prepared by injecting alum-precipitated antigens recovered by elution of polyacrylamide gels in which isolated ICs released from Raji cells had been electrophoresed. Other workers have previously shown successful immunization with antigen in SDS solution (37, 38) or antigen eluted from SDS-polyacrylamide gels (39) .
Evidence for circulating ICs has now been obtained in a wide variety of diseases of animals and humans. However, in many of these diseases virtually nothing is known about the identity of antigens in these ICs. Isolation of ICs from sera of patients could help in identification of etiologic agents. The principles and techniques described for isolating ICs using Raji cells could be adopted to other substances which bind ICs, e.g. Clq, rheumatoid factor, staphylococcal protein A, and conglutinin. However, Raji cells may be superior for this purpose because they specifically bind ICs, whereas substances such as Clq, rheuma-toid factor, and staphylococcal A protein are known to interact with non-IC substances such as endotoxin, DNA, monomeric Ig, viral proteins, etc. Moreover, similar techniques may be employed for the direct demonstration and isolation of ICs bound to mononuclear cells or other cells in vivo. 3 Purified antigens, even though incompletely identified, could be used diagnostically to assess the presence of specific antibodies in sera, to induce cutaneous delayed-type hypersensitivity or lymphocyte stimulation. In addition, they might be used therapeutically to stimulate a weak immune response. Furthermore, antisera raised against the isolated antigens may be useful in developing reproducible and sensitive techniques for detecting the corresponding antigens either in serum or in tissues of patients. Moreover, the availability of such antisera will allow the use of immunochemical techniques, such as affinity chromatography, to purify large quantities of respective antigens.
